Clinical Trials on Fetal Alcohol Spectrum Disorders in Australia
Total 167 results
-
Eli Lilly and CompanyCompletedSchizoaffective Disorder | Schizophrenic DisordersUnited States, France, Italy, Belgium, Mexico, Russian Federation, Puerto Rico, Taiwan, Australia, Romania, Croatia, Germany, Poland, Spain, Argentina, Brazil, Portugal, Slovakia, South Africa, Israel, Hungary, Austria, Czech Republic, Netherlan... and more
-
Boehringer IngelheimCompletedSchizophreniaUnited States, United Kingdom, Australia, Canada, France, New Zealand
-
BioCeryxUniversity of British Columbia; University College London Hospitals; Brugmann... and other collaboratorsUnknownTrisomy 21 and Other Fetal AneuploidyAustralia, United Kingdom, Spain, Canada, Belgium, Portugal
-
Jurjen LuykxUnknownSchizophrenia Spectrum and Other Psychotic DisordersAustria, Netherlands, Germany, Finland
-
Janssen Research & Development, LLCCompletedSchizophreniaGermany, Spain, Bulgaria, Romania, Austria, Belgium
-
VASCage GmbHMedical University Innsbruck; Tirol Kiniken GmbHCompletedCardiovascular Diseases | Vascular Diseases | Hypertension | Obesity | Overweight | Sleep Disorder | Atherosclerosis | Sleep | Headache | Vascular Stiffness | Cardiovascular Risk Factor | Non-Alcoholic Fatty Liver Disease | Life Style | Cardiovascular PathologyAustria
-
Forest LaboratoriesCompletedAutistic Disorder | Autism | Asperger's Disorder | Autism Spectrum Disorder (ASD) | Asperger's | Pediatric Autism | Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)United States, Belgium, Colombia, Estonia, Hungary, Iceland, Italy, Korea, Republic of, New Zealand, Poland, Serbia, South Africa, Spain, Ukraine, Australia, Canada, France, Singapore
-
Novo Nordisk A/SNot yet recruitingAlcohol-related Liver DiseaseSpain, Denmark, United States, Australia, Canada, Netherlands, Italy, Bulgaria, Czechia, Germany, Greece, France, Japan, Poland
-
Dr. Inge WinterUniversität MünsterRecruitingSchizophrenia and Related Disorders | Early Treatment-ResistanceAustria, Germany, Italy, Spain, United Kingdom
-
Alkermes, Inc.CompletedSchizophrenia | Schizophreniform Disorder | Bipolar I DisorderUnited States, Bulgaria, Russian Federation, Ukraine, Austria, Ireland, Israel, Italy, Korea, Republic of, Poland, United Kingdom, Serbia, Puerto Rico
-
AstraZenecaCompletedSchizophreniaItaly, Germany, Austria, Spain, Denmark
-
Sciwind Biosciences APAC CO Pty. Ltd.Hangzhou Sciwind Biosciences Co., Ltd.CompletedObesity | Type 2 Diabetes Mellitus | Nonalcoholic SteatohepatitisAustralia
-
Johnson & Johnson Pte LtdCompletedSchizophreniaAustralia, China, Hong Kong, Taiwan, Malaysia, Korea, Republic of, New Zealand, Thailand, Philippines
-
Janssen-Ortho Inc., CanadaTerminatedSchizophreniaCanada, United Kingdom, Australia, Ireland
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH); Yale University; OrygenRecruitingPsychosis | Remission | Conversion | Clinical High RiskUnited States, United Kingdom, Canada, Italy, Australia, Chile, China, Denmark, Germany, Hong Kong, Korea, Republic of, Singapore, Spain, Switzerland
-
Rene KahnCompletedUltra High Risk for PsychosisSpain, Austria, Germany, Israel, Italy, Netherlands, Norway, Switzerland, United Kingdom
-
Eli Lilly and CompanyCompletedSchizophreniaGermany, Mexico, Austria, Croatia, Romania, Russian Federation, Argentina, Portugal, South Africa
-
AstraZenecaRecruitingNon-alcoholic Steatohepatitis (NASH)Austria, Germany, Japan, Sweden
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka America PharmaceuticalCompletedSchizophreniaAustria, United Kingdom, France, Spain, Sweden, Czech Republic, Denmark, Finland, Germany
-
Otsuka Pharmaceutical Development & Commercialization...CovanceCompletedSchizophreniaSpain, Korea, Republic of, United States, Russian Federation, Chile, Estonia, Finland, Mexico, Hungary, Bulgaria, Croatia, Serbia, France, Poland, Romania, Thailand, Puerto Rico, Slovakia, Taiwan, Australia, India, Argentina, South... and more
-
Alkermes, Inc.CompletedSchizophrenia | Bipolar I Disorder | Schizophreniform DisordersUnited States, Korea, Republic of, Russian Federation, Ukraine, Austria, Germany, Ireland, Israel, Italy, Poland, Spain, United Kingdom
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaUnited States, India, South Africa, Estonia, Russian Federation, Mexico, Korea, Republic of, Malaysia, Bulgaria, Hungary, Croatia, Serbia, Poland, Romania, Puerto Rico, Slovakia, Chile, Taiwan, Thailand, Australia, Spain, Argentina, Finlan... and more
-
Denovo Biopharma LLCTerminatedSchizophreniaGermany, Spain, United States, Belgium, France, Sweden, Austria, Poland, Puerto Rico, Romania
-
Hoffmann-La RocheCompletedSchizophreniaUnited States, Poland, Hungary, Russian Federation, Germany, Austria, France, Brazil, Japan, Mexico
-
AstraZenecaCompletedSchizophreniaUnited States, Bulgaria, Spain, Estonia, Hungary, Latvia, Finland, Canada, Germany, Italy, Lithuania, Australia
-
Eli Lilly and CompanyTerminatedSchizophreniaGermany, Spain, United States, Sweden, Austria, France, Poland, Puerto Rico, Romania, Brazil, Greece
-
Janssen Research & Development, LLCCompletedSchizophreniaFrance, United States, China, Spain, Argentina, Mexico, Portugal, Bulgaria, Germany, Poland, Russian Federation, Ukraine, Japan, Greece, Taiwan, Korea, Republic of, Canada, Czech Republic, Brazil, Hungary, Austria, Sweden, Romania, Sl... and more
-
FORUM Pharmaceuticals IncSyneos Health; NeuroCog Trials, Inc.CompletedSchizophrenia | Impaired CognitionUnited States, Ukraine, United Kingdom, Poland, Romania, Russian Federation, Italy, Mexico, Colombia, Argentina, Australia, Brazil
-
Hoffmann-La RocheCompletedSchizophreniaKorea, Republic of, United States, Hungary, Russian Federation, Argentina, Colombia, India, Australia, Finland, France, Mexico, Romania, Sweden, United Kingdom
-
Hoffmann-La RocheCompletedSchizophreniaFinland, Sweden, Korea, Republic of, United States, Colombia, France, Russian Federation, Australia, Hungary, Romania, Mexico, United Kingdom, Argentina, India
-
Boehringer IngelheimActive, not recruitingClinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)SchizophreniaSweden, Canada, Italy, Japan, United States, Turkey, Greece, Germany, China, New Zealand, Australia, Mexico, Philippines, Poland, Brazil, Colombia, Norway
-
Janssen Research & Development, LLCCompletedSchizophreniaUnited States, Korea, Republic of, Hong Kong, Taiwan, Malaysia, Czechia, Poland, Brazil, India, Spain, Argentina, Bulgaria, Turkey, Russian Federation, Ukraine, Hungary, South Africa, Mexico, Australia, France, Italy
-
Boehringer IngelheimCompletedSchizophreniaSpain, Korea, Republic of, United Kingdom, Taiwan, United States, Austria, Italy, Germany, Poland, Japan, Canada
-
Hoffmann-La RocheCompletedSchizophreniaSpain, Turkey, France, Russian Federation, Italy, Czech Republic, Australia
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaKorea, Republic of, United States, Estonia, Italy, Hungary, Bulgaria, Croatia, France, Poland, Thailand, Puerto Rico, Chile, South Africa, Austria, Belgium
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka America PharmaceuticalCompletedSchizophreniaBelgium, Spain, Italy, Austria, Germany, France, Czech Republic, United Kingdom, Greece, Hungary
-
Eli Lilly and CompanyCompletedSchizophreniaUnited States, United Kingdom, Spain, Argentina, Mexico, Brazil, Peru, Puerto Rico, Germany, Austria, Ireland, Venezuela
-
UMC UtrechtCompletedSchizophreniaNetherlands, Norway, Austria, Belgium, Bulgaria, Czechia, Denmark, Germany, Greece, Hungary, Israel, Italy, Poland, Romania, Spain, United Kingdom
-
Boehringer IngelheimActive, not recruitingSchizophreniaUnited States, United Kingdom, Taiwan, Germany, Bulgaria, Mexico, Argentina, Denmark, Korea, Republic of, Austria, China, Belgium, Czechia, Finland, Serbia, Brazil, Portugal, Lithuania
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSchizophreniaUnited States, Ukraine, Germany, Spain, India, Russian Federation, Czech Republic, Austria, Hungary, Lithuania, Bulgaria, Estonia, Poland, France
-
La Jolla Pharmaceutical CompanyPRA Health SciencesCompletedHereditary HemochromatosisUnited States, Australia, France, United Kingdom
-
Janssen-Cilag International NVCompletedSchizophreniaFrance, Ukraine, United Kingdom, Germany, Spain, Israel, Portugal, Turkey, Greece, Sweden, Belgium, Netherlands, Hungary, Denmark, Lithuania, Latvia, Croatia, Estonia, Austria, Switzerland
-
Orthopedic Hospital Vienna SpeisingCompleted
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka America PharmaceuticalCompletedSchizophreniaTurkey, Austria, Germany, South Africa, Sweden, Finland, Czech Republic, Poland, France, Hungary, United Kingdom, Switzerland
-
Novo Nordisk A/SCompletedNon-alcoholic Steatohepatitis | Hepatobiliary DisordersUnited States, Russian Federation, United Kingdom, Denmark, Sweden, Netherlands, Austria, Belgium, Spain, France, Bulgaria, Canada, Australia, Greece, Japan, Finland, Puerto Rico
-
FORUM Pharmaceuticals IncSyneos HealthCompletedSchizophrenia | Impaired CognitionUnited States, Ukraine, United Kingdom, Germany, Spain, Argentina, Canada, Singapore, Russian Federation, Italy, Mexico, Colombia, Australia, Belgium, Poland, Romania
-
Queen Silvia Children's Hospital, Gothenburg, SwedenSahlgrenska University Hospital, Sweden; Swedish Heart Lung FoundationRecruitingAortic Valve Stenosis | Congenital Heart Disease | Hypoplastic Left Heart Syndrome | Fetal Cardiac DisorderUnited States, Austria, Canada, Finland, Germany, Poland, Spain, Sweden
-
FORUM Pharmaceuticals IncSyneos Health; NeuroCog Trials, Inc.CompletedSchizophrenia | Impaired CognitionUnited States, Australia, Poland, Ukraine, Germany, Spain, Argentina, Serbia, Canada, Singapore, Russian Federation, Brazil, Mexico
-
Novartis PharmaceuticalsCompletedIron Overload | Hereditary HemochromatosisUnited States, Germany, Italy, Australia, Canada, France
-
The Deutsche Diabetes Forschungsgesellschaft e.V.Novo Nordisk A/S; Boehringer Ingelheim; Federal Ministry of Health, Germany; German... and other collaboratorsRecruitingType 2 Diabetes | Non-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)Germany, Austria